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Abstract
Background: Chronic fatigue syndrome (CFS) is a disabling condition that affects approximately
800,000 adult Americans. The pathophysiology remains unknown and there are no diagnostic
markers or characteristic physical signs or laboratory abnormalities. Most CFS patients complain
of unrefreshing sleep and many of the postulated etiologies of CFS affect sleep. Conversely, many
sleep disorders present similarly to CFS. Few studies characterizing sleep in unselected CFS
subjects have been published and none have been performed in cases identified from population-
based studies.
Methods: The study included 339 subjects (mean age 45.8 years, 77% female, 94.1% white)
identified through telephone screen in a previously described population-based study of CFS in
Wichita, Kansas. They completed questionnaires to assess fatigue and wellness and 2 self-
administered sleep questionnaires. Scores for five of the six sleep factors (insomnia/hypersomnia,
non-restorative sleep, excessive daytime somnolence, sleep apnea, and restlessness) in the Centre
for Sleep and Chronobiology's Sleep Assessment Questionnaire© (SAQ©) were dichotomized
based on threshold. The Epworth Sleepiness Scale score was used as a continuous variable.
Results: 81.4% of subjects had an abnormality in at least one SAQ© sleep factor. Subjects with
sleep factor abnormalities had significantly lower wellness scores but statistically unchanged fatigue
severity scores compared to those without SAQ© abnormality. CFS subjects had significantly
increased risk of abnormal scores in the non-restorative (adjusted odds ratio [OR] = 28.1; 95%
confidence interval [CI]= 7.4–107.0) and restlessness (OR = 16.0; 95% CI = 4.2–61.6) SAQ© factors
compared to non-fatigued, but not for factors of sleep apnea or excessive daytime somnolence.
This is consistent with studies finding that, while fatigued, CFS subjects are not sleepy. A strong
correlation (0.78) of Epworth score was found only for the excessive daytime somnolence factor.
Conclusions: SAQ© factors describe sleep abnormalities associated with CFS and provide more
information than the Epworth score. Validation of these promising results will require formal
polysomnographic sleep studies.
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Background
Chronic Fatigue Syndrome (CFS) is a disabling condition
affecting an estimated 142 to 560 per 100,000 adults in
the United States [1,2]. The pathophysiology remains
unknown, and infectious etiologies, immune dysfunc-
tion, stress, dysautonomia, and abnormalities in the
hypothalamic-pituitary axis are among current hypothe-
ses being investigated. Of course none of these hypotheses
are mutually exclusive as known and postulated pathways
inter-relate and integrate these diverse physiologic
processes.
Sleep physiology may be central to understanding CFS.
Unrefreshing sleep is the most prevalent of the 8 CFS case-
defining symptoms, being endorsed by 88–95% of cases
identified in population-based studies [1,3] and 70–80%
of cases in clinic-based studies [4,5]. Most of the postu-
lated etiologies of CFS affect sleep, e.g. infection,
cytokines, stress, and hormones. Sleep deprivation or
experimental disruption of sleep is known to produce
many of the features of CFS, including fatigue, impaired
cognition, and even joint pain and stiffness [6-10].
While sleep problems figure prominently in CFS symp-
toms, primary sleep disorders, such as sleep apnea and
narcolepsy, are exclusionary conditions for the diagnosis
under the current research case definition [11]. According
to DSM-IV classification, primary sleep disorders are those
not related to known etiologies of sleep pathology, e.g.
mental disorders (most commonly depression or anxi-
ety), medical conditions, and substance use (including
alcohol, caffeine, medications and illegal drugs)[12].
Clearly primary sleep disorders must be considered in the
differential diagnosis of CFS, as most patients with these
conditions will respond to therapy. However, at some
level, including sleep abnormalities as both a case defin-
ing symptom and an exclusionary diagnosis introduces
confusion into CFS diagnosis, management and research.
Is CFS a condition that explains sleep disturbance, or
could an underlying sleep pathology result in or contrib-
ute to development of CFS? Accurately identifying the
relationship of sleep abnormalities to CFS requires as a
start, characterizing sleep in persons with CFS. Formal
sleep studies require all-night polysomnography. Polys-
omnography records brain, muscle, heart, eye, and respi-
ratory activity as well as oxygen saturation throughout the
night. Results define sleep architecture, duration and tim-
ing of sleep, respiratory obstruction and abnormal limb
movements. Interpretation requires expertise and judi-
cious interpretation.
Because of the complexity and expense of formal sleep
testing, few studies characterizing sleep in unselected CFS
subjects are available, and none have been performed in
cases identified from population-based studies. Inefficient
sleep (i.e. more time in bed awake) has been consistently
documented [4,13-16]. Several studies have also
described an alpha electroencephalogram (EEG) arousal
disturbance during non-rapid eye movement sleep
[17,18]. The reported prevalence of undiagnosed primary
sleep disorders (sleep apnea, narcolepsy, and restless leg
syndrome/periodic limb movements in sleep) varies from
0% to 50% of CFS patients [4,5,13,14,16,19,20]. This no
doubt reflects differences in case ascertainment as well as
selection criteria, and emphasizes the importance of
excluding a treatable primary sleep disorder when evalu-
ating patients with unexplained fatigue.
The purpose of this study was to describe sleep character-
istics of persons with CFS identified in the general popu-
lation of Wichita, Kansas [2]. We used two brief self-
administered questionnaires to screen and profile sleep
abnormalities; the Epworth Sleepiness Scale [21] and the
Centre for Sleep and Chronobiology Sleep Assessment
Questionnaire© (SAQ©) [22-25] (see Additional file: 1).
We correlated results with subject variables potentially
associated with sleep abnormalities (age, sex, neck cir-
cumference, and body mass index [BMI]) and with meas-
ures of wellness and fatigue. If validated by formal sleep
studies, simple screening tools like the SAQ© have the
potential to improve the accuracy of case ascertainment in
population-based epidemiologic studies and to facilitate
the identification of treatable primary sleep disorders in
patients presenting with clinically unexplained fatigue.
Methods
Design
This study adhered to human experimentation guidelines
of the U.S. Department of Health and Human Services
and the Helsinki Declaration. The Centers for Disease
Control and Prevention Human Subjects committee
approved study protocols. All participants were volunteers
who gave informed consent.
Details of the population-based study developed to esti-
mate the prevalence and incidence of CFS are published
[2]. In brief, a random digit-dialing telephone survey
screened 56,146 people, interviewed in detail 3,528 who
reported fatigue of at least 1 month's duration and 3,634
randomly selected non-fatigued people. The detailed
interview was structured to detect exclusionary medical
and psychiatric diagnoses and identify criteria specified in
the 1994 research case definition of CFS [11]. At baseline
all subjects meeting criteria for CFS on the telephone and
randomly selected non-fatigued subjects were invited to
clinic for further medical and psychiatric evaluation. In
accordance with CFS case definition, subjects endorsing
sleep apnea or narcolepsy in the telephone interview or
during the clinical evaluation were excluded. HoweverBMC Neurology 2004, 4 http://www.biomedcentral.com/1471-2377/4/6
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other potential primary sleep disorders were not specifi-
cally addressed with targeted questions.
The objective of clinical evaluation was to classify subjects
as CFS or other conditions [11]. Clinical evaluation
included screening laboratory tests, complete physical
examination, psychiatric screening, estimation of fatigue
severity, assessment of symptomatology, and well being
[2]. Approximately 48% of persons meeting criteria for
CFS on telephone interview have a medical or psychiatric
condition identified during clinical evaluation that could
account for their illness [2]. Most (64%) have an abnor-
mal physical finding or laboratory test and the remainder
have an exclusionary psychiatric condition [2]. The most
common exclusionary psychiatric conditions are major
depressive disorder with melancholic or psychotic fea-
tures (55% of psychiatric exclusions) followed by bipolar
disorder (36%). Other exclusionary psychiatric condi-
tions include schizophrenia, delusional disorders,
dementias, organic brain disorders, alcohol or substance
abuse, anorexia nervosa, and bulimia.
In the second year of the study all subjects previously eval-
uated at the clinic (both fatigued and non-fatigued), and
newly identified fatigued subjects fulfilling criteria for CFS
were invited to clinic. Subjects evaluated in clinic during
the second year completed the SAQ© and Epworth Sleepi-
ness Scale described below.
Fatigue groups
Data from both the baseline and second year clinical eval-
uations were used to classify subjects into one of 6 mutu-
ally exclusive fatigue groups:
1) Never fatigued. Those who did not report fatigue at
either baseline or year two, and had no identified medical
or psychiatric exclusions;
2) Not currently fatigued but fatigued at baseline. Those
who reported fatigue at baseline but were not classified as
CFS, and who reported no fatigue at year two and were
without medical or psychiatric exclusions;
3) Insufficient symptoms or fatigue. Fatigued subjects
without exclusionary diagnoses but with insufficient
symptoms or fatigue severity to be classified as CFS at
either visit;
4) Medical or psychiatric exclusions. Subjects with current
medical or psychiatric conditions that could explain
fatigue and are thus considered exclusions for the diagno-
sis of CFS [11];
5) Chronic fatigue syndrome in remission. Subjects classi-
fied as CFS at baseline who were fatigued at year two, do
not have medical or psychiatric exclusions, but lack
number of symptoms or fatigue severity for current diag-
nosis of CFS;
6) CFS. Subjects currently meeting all criteria of the 1994
CFS research case definition [11].
Sleep questionnaires
The SAQ© was developed to screen for primary sleep disor-
ders and sleep abnormalities in epidemiologic studies
[22-26]. The questionnaire includes 17 items scored on a
5 point Likert scale from 1 (never) to 5 (always). Data
from questionnaires completed by subjects referred for
formal sleep testing at the Sleep Disorders Clinic of the
Centre for Sleep and Chronobiology as well as 30 healthy
volunteers similarly evaluated as controls were used to
define the performance of the questionnaire [22,23]. Prin-
cipal component analysis identified 6 factors labeled 1)
insomnia/hypersomnia, 2) non-restorative sleep, 3) sleep
schedule disorder, 4) excessive daytime somnolence, 5)
sleep apnea, and 6) restlessness. Threshold values for
detection of an abnormality in each factor were selected to
optimize sensitivity and specificity using receiver operator
characteristic curves to distinguish factor scores from sub-
jects with validated primary sleep disorders and controls.
Values for the insomnia/hypersomnia factor (insomnia)
factor were based on data from 56 subjects with a diagno-
sis of psychophysiological or idiopathic insomnia. The
non-restorative sleep factor score threshold was deter-
mined based on data for 81 CFS or fibromyalgia patients
with alpha EEG arousal disturbance during non-rapid eye
movement sleep [24]. The excessive daytime somnolence
factor score threshold was determined based on data from
32 subjects with narcolepsy or idiopathic hypersomno-
lence [25]. The threshold for the sleep apnea score was
determined from data on 450 subjects with obstructive or
central sleep apnea, and that for the restlessness factor
based on data from 109 subjects with restless leg syn-
drome or periodic involuntary limb movements in sleep
[25]. Thresholds for the sleep schedule factor score have
not been determined so this factor was not included in the
current study. Factor scores above threshold indicate the
presence of a sleep abnormality characteristic of the pri-
mary sleep disorder used to norm the score. Factor scores
above threshold had sensitivities varying between 79–
100% and specificities between 68–96% for detection of
abnormality in the respective primary sleep disorder
group [26]. It is important to stress that derivation of
SAQ© factor scores was not based on the same population
as the one studied here. Completed SAQs© were sent to the
Sleep Disorder Clinic of the Centre for Sleep and Chrono-
biology for blind scoring.
The Epworth Sleepiness Scale was designed to distinguish
the daytime sleepiness experienced by narcolepticBMC Neurology 2004, 4 http://www.biomedcentral.com/1471-2377/4/6
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patients from that of normal subjects. It consists of eight
questions asking the respondent to rate the potential for
falling asleep in sedentary situations on a 4-point Likert
scale from 0 (never) to 3 (high chance)[21]. The total of
the responses (0–24) is the Epworth score. Using a cut-off
of >10, the Epworth scores had 93.5% sensitivity and
100% specificity for distinguishing narcopletic subjects
from controls [27].
Statistical analyses
We used F-tests, t-tests, or Kruskal-Wallis tests to compare
groups with respect to continuous variables and χ2 or
Fisher-exact tests for categorical data. Group one compar-
isons were performed using the Bonferroni adjustment.
BMI was categorized according to NIH clinical guidelines
(<18.5 underweight, 18.5 to 24.9 normal, 25.0 to 29.9
overweight, 30.0 to 39.9 obese, ≥ 40 extreme obesity)[28].
Men with neck circumference ≥ 43.18 cm (17 inches) and
women with neck circumference ≥ 40.64 cm (16 inches)
were classified as having large neck sizes, a correlate of
sleep apnea [29]. Univariate logistic regression models
estimated odds ratios and 95% confidence intervals for
the associations between SAQ© factors above threshold,
age, sex, BMI, neck circumference, fatigue severity (meas-
ured by the Fatigue Assessment Instrument [30]) and self-
reported wellness scores (assessed from the question:
"During the past 4 weeks, where would you place yourself
in terms of energy, wellness, and ability to complete your
every day activities on a scale from 1 to 100?"). Epworth
scores were correlated with SAQ© factor scores, age, BMI,
neck circumference, fatigue severity and wellness scores.
Because we were primarily interested in the association
between sleep abnormalities and fatiguing illnesses, and
because of the correlations among the potential predictors
of sleep disorders, we used a forward selection process to
determine multivariate models. We included the fatigue
groups first, and then selected from the remaining pool of
variables. We used the Hosmer and Lemeshow statistic to
evaluate how well the data fit the final logistical model
[31]. All tests were 2-sided and p-values were considered
significant if they did not exceed 0.05. All analyses were
performed using SAS version 8.1 (SAS Institute, Inc., Cary,
NC).
Results
Sample characteristics
One subject attending the clinic was dropped from analy-
sis because missing data did not permit scoring of any fac-
tor in the SAQ©. Demographic and clinical characteristics
of the remaining 339 subjects in the sample are shown in
Table 1 along with the distribution of these characteristics
by fatigue group. Over half the fatigued subjects (145/
277, 52.3%) as well as one not fatigued subject had exclu-
sionary medical or psychiatric conditions identified dur-
ing the clinical evaluation. Medical exclusions identified
during the clinic visit included abnormal blood or urine
tests, abnormal Romberg test, adrenal insufficiency, blad-
der tumor, BMI = 47, cerebral palsy, chronic hepatitis,
emphysema, heart disease within 2 years of evaluation,
hypertension, hypothyroidism, inflammatory bowel dis-
ease, kidney cancer, lupus, melanoma, uncontrolled dia-
betes, rheumatoid arthritis, self-reported sleep apnea and
Table 1: Demographic and clinical characteristics overall and by fatigue group
Overall NF NF | F ISF M/P CFS-R CFS
No. (%) 339 41 (12.1) 21 (6.2) 90 (26.6) 145 (42.8) 18 (5.3) 24 (7.1)
Mean Age, years (SD) 45.8 (10.9) 46.9(13.0) 40.6(8.2) 44.5(11.2) 47.3(10.5) 46.4(7.5) 44.7(10.4)
Female (%) 77.0 63.4 71.4 74.4 83.5 72.2 79.2
White (%) 94.1 92.7 100.0 91.1 96.6 83.3 95.8
Education > High School(%) 65.5 80.5 66.7 62.2 63.5 55.6 70.8
Income > $40,000/yr (%) 47.5 58.5 61.9 44.4 43.5 66.7 37.5
Mean BMI (SD)* 28.5 (6.3) 25.3(4.7) 28(5.7) 28.6(6.4) 29.5(6.7) 28.6(5.2) 28.2(6.0)
<18.5: Underweight (%) 3.6 7.3 4.8 2.2 2.8 0.0 8.3
18.5–24.9: Normal (%) 25.7 36.6 23.8 27.8 23.6 22.2 16.7
25–29.9: Overweight (%) 30.5 41.5 33.3 26.7 27.8 38.9 33.3
30–39.9: Obesity (%) 32.8 14.6 33.3 33.3 36.1 33.3 41.7
≥ 40: Extreme obesity (%) 7.4 0.0 4.8 10.0 9.7 5.6 0.0
Neck circumference (cm) Mean (SD) 36.4 (3.8) 35.7 (3.9) 36.4 (3.7) 36.8 (4.1) 36.4 (3.8) 36.3 (2.6) 36.3 (3.3)
≥ 43.18 cm in males (%) 12.8 0.0 16.7 17.4 20.8 0.0 0.0
≥ 40.64 cm in females (%) 6.3 7.7 0.0 12.1 4.2 7.7 0.0
Years fatigued, median (Range) 6.8 (0.3–55.5) -------- -------- 5.9 (0.5–40.8) 7.2 (0.3–55.5) 8.6 (2.1–39.7) 6.5 (1.4–47.8)
Mean Wellness score (SD)† 53.0 (22.7) 85.5(14.9) 70.5(17.2) 51.9 (17.0) 44.0 19.3) 56.4 19.2) 39.8 (18.3)
Fatigue severity score Mean (SD)† 5.4 (1.0) ------- ------ 5.0 (0.9) 5.5 (1.0) 5.6 (0.8) 6.0 (0.6)
*P = 0.0157; † P < 0.0001 NF – never fatigued; NF|F – baseline fatigue currently not fatigued; ISF – insufficient symptoms or fatigue for CFS; M/P – 
medical or psychiatric exclusion; CFS-R – baseline CFS currently remission; CFS – currently CFSBMC Neurology 2004, 4 http://www.biomedcentral.com/1471-2377/4/6
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narcolepsy, and major surgery within the past year. Psy-
chiatric disorders included anorexia or bulimia nervosa,
bipolar disorder, delusional disorder, and major
depressive disorder with melancholic features.
Age, sex, race, education, income and mean neck circum-
ference were similar across groups, as was duration of
fatigue. The groups differed significantly with respect to
BMI (P = 0.0157). Never fatigued subjects were signifi-
cantly less obese than subjects who had ever been fatigued
(mean = 25.3, standard deviation [SD] = 4.7, and mean =
28.9, SD = 6.4, respectively, P < 0.0001). The mean well-
ness scores were significantly higher in never fatigued and
subjects not currently reporting fatigue than in any of the
currently fatigued groups (P < .0017). Fatigue severity was
evaluated only in currently fatigued subjects. The mean
scores differed across the fatigue groups, with lowest value
reported in the ISF group and highest in CFS. Interest-
ingly, the CFS-remission and CFS groups had statistically
indistinguishable mean wellness and fatigue severity
scores.
Abnormalities in SAQ© factor scores
Abnormalities in each of the 5 SAQ© sleep factors dichot-
omized according to score above or below threshold are
summarized in Table 2 (see Additional file: 2). Sample
sizes varied slightly (n = 331 to 339) because of missing
data for individual sleep factor scores. The never fatigued
group served as reference when assessing the association
between fatiguing illnesses and abnormalities in SAQ© fac-
tors of sleep apnea, restlessness and excessive daytime
somnolence. For the insomnia and excessive daytime
somnolence factors, the never and not currently fatigued
groups were combined as reference because insufficient
numbers of never fatigued subjects scored positive for
these factors.
Overall, 81.4% of study subjects scored positive in at least
one sleep factor. Those with at least one abnormal sleep
factor had significantly lower wellness scores (mean =
48.9, SD = 20.9) than those without any (mean = 71.7, SD
= 20.9), P < 0.0001). However fatigue severity scores were
not significantly different in these two groups. Restricting
analysis of wellness scores to those currently fatigued
showed a similar effect; those with one or more abnormal
sleep factors had lower wellness scores (mean = 46.0, SD
= 19.0) than those with no abnormalities (mean = 56.7,
SD = 16.4), P = 0.006. Abnormalities in the sleep apnea
and insomnia factors were identified least frequently
(approximately 28% of sample) and restlessness most fre-
quently (51.6%). The mean number of abnormal sleep
factors per individual varied by fatigue status (P <
0.0001), being highest in subjects with an exclusionary
diagnosis (2.4) and lowest in those never fatigued (0.4).
Univariate odds ratios for demographic and fatigue group
variables showed differences for each of the five SAQ©
sleep factors. Women were almost half as likely as men to
be positive for sleep apnea (OR = 0.57) and about twice as
likely to be positive for the non-restorative sleep and
insomnia factors (OR = 2.26 and 2.09 respectively).
Increased age was minimally associated only with non-
restorative and insomnia factors. BMI as a continuous var-
iable showed an increased association with the sleep
apnea, restlessness and excessive daytime somnolence fac-
tors. Most of the BMI effect on sleep factors was concen-
trated in the obesity/extreme obesity stratum (≥ 30; OR =
1.93, 2.62, and 2.52 respectively). The Pearson correlation
between neck circumference and BMI was 0.55 (0.69
among men, 0.72 among women). Neck circumference as
a continuous variable was only significantly associated
with the sleep apnea factor.
For all sleep factors, fatigued subjects tended to have sig-
nificantly increased odds ratios compared to non-
fatigued. However there was considerable variation in the
extent of this association. The sleep apnea and excessive
daytime somnolence factors showed the least association
with fatigue groups. Significantly increased odds ratios for
the sleep apnea factor were noted only for insufficient
symptoms/fatigue and exclusionary diagnoses groups
(3.66 and 2.92, respectively). Increased odds ratios for
excessive daytime somnolence were found only for insuf-
ficient symptoms/fatigue, exclusionary diagnoses and
CFS-remission groups (5.15, 5.75 and 3.78 respectively).
All fatigue groups showed significantly increased odds
ratio for the insomnia factor, with the magnitude being
greatest for the subjects with exclusionary diagnoses
(12.73) and similar for CFS-remission and CFS groups
(8.05 and 9.66 respectively). By contrast, while the odds
ratios for the restlessness and non-restorative factors were
also increased in all fatigue groups; the magnitude of the
odds ratio was greatest for CFS (18.5 for restlessness and
24.16 for nonrestorative) and lowest in CFS-remission
(5.89 for restlessness and 12.89 for nonrestorative).
Multivariate logistic regression models with forward selec-
tion estimated the additional effect of female sex, age, cat-
egories of BMI, and neck circumference in centimeters,
after including the fatiguing illness subgroups. Again dif-
ferent predictors were associated with the individual sleep
factor abnormalities (Table 2). The model did not change
the pattern or magnitude of the associations of fatigue
groups with each sleep factor noted in the univariate anal-
ysis. The strongest association was between CFS and non-
restorative sleep. CFS was also more strongly associated
than any other fatigue category with the restlessness fac-
tor. In addition the CFS-remission group showed odds
ratio only half that of CFS for the non-restorative factor
and less than half that of CFS for restlessness. SubjectsBMC Neurology 2004, 4 http://www.biomedcentral.com/1471-2377/4/6
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with medical or psychiatric exclusionary conditions
showed the strongest association with insomnia and were
second only to CFS in strength of association with non-
restorative sleep and restlessness. As might be expected,
larger neck circumference remained significantly associ-
ated with abnormalities in the sleep apnea factor after
accounting for fatiguing illnesses. Having a BMI ≥ 30,
compared with normal BMI, predicted restlessness, and
excessive daytime sleepiness, but not sleep apnea. Older
current age was the only predictor of non-restorative
sleep, after fatiguing illness was considered. No additional
predictors entered the model for insomnia after including
the fatigue groups.
Description of the Epworth scale, overall, by sex and by
fatigue group is displayed in Table 3. Non-fatigued sub-
jects had scores similar to those described in normal con-
trols [21] and fatigued subjects had scores in the high
normal range. Significant differences were found only for
the comparison of the never fatigued and exclusionary
diagnoses groups and the never fatigued and insufficient
symptoms/fatigue groups (P < 0.0017). Females had
slightly higher mean scores than males, but the difference
was not significant. Table 4 displays the Pearson correla-
tion coefficients between the Epworth score and the SAQ©
factor scores, age and clinical variables. The only correla-
Table 3: Adjusted odds ratios and 95% confidence intervals for abnormalities in SAQ factors using logistic regression models with 
forward selection
Variable* Sleep Apnea Restlessness Non-restorative Insomnia Excessive Daytime Sleepiness
Fatigue group
NF 1.0 1.0 1.0 1.0 1.0
NF|F 3.50 (0.93,13.16) 11.13(2.86,43.26) 1.0 1.0 2.13(0.62,7.32)
ISF 3.50 (1.22,10.01) 7.91(2.57,24.34) 5.37 (1.73,16.67) 6.25(1.78,21.96) 4.80(1.89,12.21)
M/P 2.83 (1.02,7.83) 14.19(4.73,42.55) 21.50(7.30,63.38) 12.73(3.80,42.63) 5.26(2.14,12.94)
CFS-R 2.74 (0.67,11.18) 5.23(1.27,21.57) 13.63 (3.33,55.81) 8.05 (1.69,38.34) 3.48(0.99,12.25)
CFS 2.06 (0.52,8.23) 16.02(4.17,61.55) 28.10 (7.38,106.99) 9.66 (2.30,40.69) 2.41(0.74,7.82)
Female --- --- --- --- ---
Age (years) --- --- 1.05 (1.02,1.07) --- ---
BMI --- --- ---
<18.5 1.76(0.45,6.84) 2.57(0.70,9.35)
18.5–24.9 1.0 1.0
25–29.9 1.44(0.78,2.68) 1.60(0.86,2.98)
≥ 30 2.18(1.21,3.91) 2.26(1.27,4.04)
Neck circumference (cm) 1.13 (1.05,1.20) --- --- --- ---
Goodness-of-fit P† 0.9244 0.7933 0.0701 1.0000 0.6676
*Fatigue groups were included in all models; other variables entered the models using a forward selection method †Hosmer-Lemeshow statistic ---: 
variable did not satisfy forward selection algorithm NF and NF|F reference for non-restorative sleep and insomnia; NF reference for all other SAQ 
Factors NF – never fatigued; NF|F – baseline fatigue currently not fatigued; ISF – insufficient symptoms or fatigue for CFS; M/P – medical or 
psychiatric exclusion; CFS-R – baseline CFS currently remission; CFS – currently CFS
Table 4: The Epworth scale by sex and fatigue group
Mean (SD) Median (Range)
All subjects 10.2 (5.3) 11.0 (0–23)
Male 9.6 (5.5) 9.0 (0–22)
Female 10.4 (5.3) 11.0 (0–23)
Fatigue groups* NF 6.0 (4.3) 5.0 (1–17)
NF|F 8.4 (4.9) 7.0 (1–18)
ISF 11.1 (5.0) 11.0 (1–23)
M/P 11.3 (5.3) 12.0 (0–22)
CFS-R 9.8 (6.4) 8.5 (1–22)
CFS 9.4 (4.5) 9.5 (2–18)
* P < 0.0001 NF – never fatigued; NF|F – baseline fatigue currently not fatigued; ISF – insufficient symptoms or fatigue for CFS; M/P – medical or 
psychiatric exclusion; CFS-R – baseline CFS currently remission; CFS – currently CFSBMC Neurology 2004, 4 http://www.biomedcentral.com/1471-2377/4/6
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tion of note was with the excessive daytime somnolence
factor (0.78).
Discussion
The vast majority of the study population (81.4%) had an
abnormal score in at least one sleep factor. The prevalence
of sleep abnormalities is lowest in the never fatigued
group, but with nearly one-third (29.3%) scoring positive
in one or more factors, the value is higher than might be
expected. However the pattern of the sleep abnormalities
in this control group (e.g. highest for excessive daytime
somnolence and sleep apnea) is compatible with the poor
sleep hygiene associated with the modern lifestyle as well
as with unrecognized sleep apnea in subjects not com-
plaining of sleep-related symptoms. Interestingly,
fatigued subjects with sleep factor abnormalities had sig-
nificantly lower wellness scores but statistically
unchanged fatigue severity scores compared to those with
no abnormalities. This suggests that the SAQ© measures of
sleep abnormalities are more important for the over-all
sense of well being than for fatigue. Other studies have
also found that measures of sleep pathology did not cor-
relate with measures of function [15,16].
Each sleep factor showed a rather characteristic risk profile
that was consistent with the intended construct for that
factor. For example, a decreased odds ratio for females
and an increased odds ratio for increased neck size were
found only for the sleep apnea factor, consistent with
known risks for polysomnography validated sleep apnea.
The non-restorative factor was normed based on CFS and
fibromyalgia patients with the alpha EEG sleep disorder
and subjects with CFS were 28 times more likely to have
abnormalities in this factor compared to non-fatigued
subjects. Interestingly, CFS subjects currently failing to
meet CFS criteria because of a reduction in symptoms or
fatigue (CSF-R) also had significantly reduced odds for
scoring abnormal in this factor. These observations are
encouraging and demonstrate the utility of the SAQ fac-
tors to characterize or profile sleep problems in fatigued
subjects. Abnormalities in the nonrestorative sleep factor
may also predict the presence of the alpha EEG sleep dis-
order, a suggestion requiring polysomnographic studies
for confirmation.
CFS subjects were also 16 times more likely than those
never fatigued to screen positive for the restlessness factor.
Again remission was associated with a reduction in the
odds ratio for this factor. Abnormalities in this factor may
relate to the inefficient sleep of CFS subjects [4,13-16].
Interestingly, abnormalities in the sleep apnea and exces-
sive daytime somnolence factors were least associated
with fatigue groups and neither was significantly associ-
ated with CFS. Again this is consistent with studies finding
that, while fatigued, CFS subjects are not sleepy. The
excessive daytime somnolence factor scores showed a
strong correlation with the Epworth Sleepiness scale that
was designed to detect pathologic sleepiness.
Second only to the CFS fatigue group, subjects with exclu-
sionary medical or psychiatric conditions were signifi-
cantly more likely than those not fatigued to have an
abnormal score in the restlessness, non-restorative and
insomnia sleep factors. The high prevalence of sleep
abnormalities in this group could be expected based on
the known impact of medications, psychiatric disease and
medical illness on sleep.
The SAQ© was developed for epidemiologic screening of
subjects to identify those to be referred for formal sleep
testing. Cut-off values for the five separate sleep factors
were established relative to specific primary sleep disor-
ders versus healthy controls. Factor scores above threshold
are intended to indicate the presence of a sleep abnormal-
ity characteristic of the primary sleep disorder used to
Table 5: Correlation of Epworth scales with SAQ© factor scores, age, BMI, neck circumference, fatigue and wellness scores.
Pearson correlation
SAQ© Factor
Sleep Apnea 0.26
Restlessness 0.23
Non-restorative 0.22
Insomnia 0.11
Excessive daytime sleepiness 0.78
Age 0.05
BMI 0.23
Neck circumference 0.10
Wellness score -0.26
Fatigue severity score 0.02BMC Neurology 2004, 4 http://www.biomedcentral.com/1471-2377/4/6
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norm the score. However factor scores do not map in a
direct one-to-one fashion to a primary sleep disorder. For
example, while the sleep apnea factor was normed to opti-
mize sensitivity and specificity of a positive score in poly-
somnography validated sleep apnea subjects, these
subjects could also score positive in other factors. This is
the first published exploration of SAQ© results in an epide-
miologic study of fatigued subjects.
The primary limitation of this study is the lack of polys-
omnography to correlate with SAQ© findings. Although
the SAQ© is promising, it has not been extensively vali-
dated. The SAQ© is also copyrighted and not available in
the public domain. Information on its utilization may be
obtained from the Center for Sleep and Chronobiology
website [26]. In addition, in this initial exploration of
sleep abnormalities in fatiguing illnesses we did not con-
trol for medication. Finally, our cross-sectional study
design cannot distinguish whether sleep abnormalities are
a result or cause of CFS.
Conclusions
Despite these limitations, our findings have importance
for the clinical assessment of unexplained fatiguing ill-
nesses as well as for research. Both sleep screening instru-
ments were easy to administer and identified potential
sleep abnormalities, however the SAQ© provided consid-
erably more information than the Epworth Sleepiness
Scale. The SAQ© sleep factors of non-restorative sleep and
restlessness are particularly associated with CFS. Further
study of the inter-relatedness of sleep pathology and
chronic fatigue is warranted. We are planning to conduct
formal sleep laboratory studies in this population to pro-
vide data that will clarify the limits of interpretation of the
SAQ© and increase the clinical and research utility of this
simple, relatively inexpensive screening questionnaire to
detect and characterize treatable primary sleep disorders
in the community.
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